Capricor Therapeutics
NASDAQ: CAPRBeverly Hills, US · Delaware corporation
Biotech
Founders & leadership
LM
Linda MarbanPresident and Chief Executive Officer, Director
RS
Rachel SmithExecutive
KK
Karen KrasneyExecutive
AB
Anthony BergmannExecutive
AH
Andrew HamerNamed on SEC filing
Board
JK
Joshua KazamBoard director
DM
David MusketBoard director
LM
Louis ManzoBoard director
EC
Earl Collier, Jr.Board director
LG
Louis GrasmickBoard director
GS
Gregory SchaferBoard director
GD
George DunbarBoard director
Reported raises · per SEC filings
Form D private placements$20.8M disclosed across 5 rounds · 2014–2017
▶$3.7MraisedMay 2017 · 4 investors · BiotechnologyRule 506(b)
▶$3.7MraisedMay 2017 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank LitvackDirector
- Deborah AscheimExecutive Officer
- Leland GershellExecutive Officer
- Earl CollierDirector
- Joshua KazamDirector
- Louis ManzoDirector
- Rachel SmithExecutive Officer
- Karen KrasneyExecutive Officer
- Linda MarbanExecutive Officer, Director
- David MusketDirector
- George DunbarDirector
- Anthony BergmannExecutive Officer
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14KraisedMar 2016 · 24 investors · BiotechnologyRule 506(b)
▶$14KraisedMar 2016 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Louis GrasmickDirector
- Linda MarbanExecutive Officer, Director
- Deborah AscheimExecutive Officer
- Louis ManzoDirector
- Anthony BergmannExecutive Officer
- Joshua KazamDirector
- Gregory SchaferDirector
- Frank LitvackDirector
- Rachel SmithExecutive Officer
- Leland GershellExecutive Officer
- David MusketDirector
- Earl Collier, Jr.Director
- Karen KrasneyExecutive Officer
- George DunbarDirector
- Offering amount
- $14K
- Amount sold
- $14K
- Placement agents
- SC&H Capital
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.1MraisedFeb 2015 · 8 investors · BiotechnologyRule 506(b)
▶$7.1MraisedFeb 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Earl Collier, Jr.Director
- Joshua KazamDirector
- Karen KrasneyExecutive Officer
- Gregory SchaferDirector
- George DunbarDirector
- David MusketDirector
- Louis GrasmickDirector
- Rachel SmithExecutive Officer
- Frank LitvackDirector
- Anthony BergmannExecutive Officer
- Andrew HamerExecutive Officer
- Louis ManzoDirector
- Linda MarbanExecutive Officer, Director
- Offering amount
- $7.1M
- Amount sold
- $7.1M
- Sales commissions
- $364.5K
- Placement agents
- H.C. Wainwright & Co., LLC, SC&H Capital
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedFeb 2015 · 39 investors · BiotechnologyRule 506(b)
▶$10MraisedFeb 2015 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joshua KazamDirector
- Louis ManzoDirector
- Earl Collier, Jr.Director
- Rachel SmithExecutive Officer
- Louis GrasmickDirector
- Karen KrasneyExecutive Officer
- Gregory SchaferDirector
- Anthony BergmannExecutive Officer
- George DunbarDirector
- Frank LitvackDirector
- David MusketDirector
- Linda MarbanExecutive Officer, Director
- Andrew HamerExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- Sales commissions
- $126.9K
- Placement agents
- H.C. Wainwright & Co., LLC, SC&H Capital
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$32.7KraisedFeb 2014 · 1 investors · Biotechnology
▶$32.7KraisedFeb 2014 · 1 investors · Biotechnology
Officers, directors & promoters on the filing
- Linda MarbanExecutive Officer, Director
- Frank LitvackDirector
- Karen KrasneyExecutive Officer
- Rachel SmithExecutive Officer
- Andrew HamerExecutive Officer
- George DunbarDirector
- Louis ManzoDirector
- Anthony BergmannExecutive Officer
- Joshua KazamDirector
- Gregory SchaferDirector
- David MusketDirector
- Louis GrasmickDirector
- Earl Collier, Jr.Director
- Offering amount
- $32.7K
- Amount sold
- $32.7K
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 05
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Capricor Therapeutics?
- Capricor Therapeutics was founded by Linda Marban.
- How much funding has Capricor Therapeutics raised?
- Capricor Therapeutics has disclosed $20.8M raised across 5 rounds.
- Where is Capricor Therapeutics headquartered?
- Capricor Therapeutics is headquartered in Beverly Hills, US.